BioNano Genomics, Inc. Forecast, price target & analysts
BioNano Genomics, Inc. Target price 2025 - Analyst rating & recommendation
BioNano Genomics, Inc. Classifications & Recommendation:
BioNano Genomics, Inc. Price Target
| Target Price | $8.16 |
| Price | $3.29 |
| Potential |
148.02%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target BioNano Genomics, Inc. 2026 .
The average BioNano Genomics, Inc. target price is $8.16.
This is
148.02%
register free of charge
$10.50
219.15%
register free of charge
$4.04
22.80%
register free of charge
|
|
| A rating was issued by 10 analysts: 7 Analysts recommend BioNano Genomics, Inc. to buy, 3 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the BioNano Genomics, Inc. stock has an average upside potential 2026 of
148.02%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 30.78 | 30.69 |
| 14.78% | 0.30% | |
| EBITDA Margin | -226.38% | -39.39% |
| 37.47% | 82.60% | |
| Net Margin | -363.94% | -74.62% |
| 43.46% | 79.50% |
6 Analysts have issued a sales forecast BioNano Genomics, Inc. 2025 . The average BioNano Genomics, Inc. sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an BioNano Genomics, Inc. EBITDA forecast 2025. The average BioNano Genomics, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 BioNano Genomics, Inc. Analysts have issued a net profit forecast 2025. The average BioNano Genomics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -88.13 | -7.39 |
| 1,194.13% | 91.61% | |
| P/E | negative | |
| EV/Sales | negative |
6 Analysts have issued a BioNano Genomics, Inc. forecast for earnings per share. The average BioNano Genomics, Inc. EPS is
This results in the following potential growth metrics and future valuations:
BioNano Genomics, Inc....
Current BioNano Genomics, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Maxim Group |
Locked
➜
Locked
|
Locked | May 20 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| Scotiabank |
Locked
➜
Locked
|
Locked | Apr 02 2025 |
| Ladenburg Thalmann |
Locked
➜
Locked
|
Locked | Nov 15 2024 |
| BTIG |
Locked
➜
Locked
|
Locked | Sep 10 2024 |
| Scotiabank |
Locked
➜
Locked
|
Locked | Aug 28 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Maxim Group:
Locked
➜
Locked
|
May 20 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 09 2025 |
|
Locked
Scotiabank:
Locked
➜
Locked
|
Apr 02 2025 |
|
Locked
Ladenburg Thalmann:
Locked
➜
Locked
|
Nov 15 2024 |
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 10 2024 |
|
Locked
Scotiabank:
Locked
➜
Locked
|
Aug 28 2024 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
